IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis

Publisher: John Wiley & Sons Inc

E-ISSN: 2056-4538|4|1|55-68

ISSN: 2056-4538

Source: The Journal Of Pathology: Clinical Research, Vol.4, Iss.1, 2018-01, pp. : 55-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content